|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.230 USD | +13.40% |
|
+14.02% | +25.52% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
| Market Cap | 696M 605M 563M 517M 977M 66.47B 992M 6.64B 2.61B 33.09B 2.62B 2.56B 111B | P/E 2026 * |
3.57x | P/E 2027 * | 3.43x |
|---|---|---|---|---|---|
| Enterprise Value | 696M 605M 563M 517M 977M 66.47B 992M 6.64B 2.61B 33.09B 2.62B 2.56B 111B | EV / Sales 2026 * |
1.51x | EV / Sales 2027 * | 1.46x |
| Free-Float |
96.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | +13.40% | ||
| 1 week | +14.02% | ||
| 1 month | +2.67% | ||
| 3 months | -4.73% | ||
| 6 months | -13.50% | ||
| Current year | +25.52% |
| 1 week | 3.55 |  | 4.28 |
| 1 month | 3.55 | | 4.88 |
| Current year | 2.95 | | 5.78 |
| 1 year | 0.72 | | 5.78 |
| 3 years | 0.53 | | 15.7 |
| 5 years | 0.53 | | 15.7 |
| 10 years | 0.53 | | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 11/03/2021 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 14/05/2026 |
Jeffrey Silber
CTO | Chief Tech/Sci/R&D Officer | - | 19/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 03/06/2021 |
Julie McHugh
CHM | Chairman | 61 | 31/03/2019 |
Marla Kessler
BRD | Director/Board Member | 56 | 31/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Free | Chief Technology Officer | 137,036 | 0.0832% | ||
| 07/07/26 | Sell | Chief Financial Officer | -127,890 | 0.0777% | ||
| 23/02/26 | Sell | Chief Executive Officer | 198,283 | 0.1219% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.40% | +14.02% | +448.35% | -62.40% | 696M | |
| +0.32% | -0.66% | +64.21% | +23.67% | 322B | |
| +0.21% | +2.87% | +33.60% | -10.34% | 71.6B | |
| -0.91% | +0.74% | +39.85% | +95.22% | 9.79B | |
| -3.60% | -2.43% | -1.16% | -6.92% | 8.39B | |
| +1.80% | -1.99% | -15.78% | -12.22% | 4.3B | |
| -0.68% | -1.87% | -34.78% | +3.04% | 3.81B | |
| +3.08% | -1.41% | -12.94% | +9.52% | 3.58B | |
| -2.15% | -3.40% | +25.70% | +40.83% | 2.59B | |
| +0.85% | +9.88% | -0.25% | -7.32% | 2.25B | |
| Average | +1.23% | +1.10% | +54.68% | +7.31% | 42.86B | |
| Weighted average by Cap. | +0.23% | -0.07% | +54.98% | +18.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 460M 400M 372M 342M 645M 43.92B 655M 4.39B 1.72B 21.87B 1.73B 1.69B 73.32B | 478M 416M 387M 355M 671M 45.66B 681M 4.56B 1.79B 22.73B 1.8B 1.76B 76.23B |
| Net income | 182M 158M 147M 135M 255M 17.34B 259M 1.73B 680M 8.63B 682M 667M 28.94B | 210M 182M 170M 156M 294M 20.03B 299M 2B 786M 9.97B 788M 771M 33.44B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$4.230 | +13.40% | 3,583,359 |
| 30/07/26 | US$3.730 | +4.78% | 1,299,350 |
| 29/07/26 | US$3.560 | -6.32% | 1,252,812 |
| 28/07/26 | US$3.800 | -2.81% | 1,821,245 |
| 27/07/26 | US$3.910 | +5.39% | 1,930,760 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
Select your edition
All financial news and data tailored to specific country editions
